Results 161 to 170 of about 21,710,721 (213)
Myocardial ‘No-Reflow’ Prevention
Current Vascular Pharmacology, 2013 Despite achievement of optimal epicardial coronary flow in the majority of patients treated for ST-segment elevation myocardial infarction (STEMI) by primary percutaneous coronary intervention (PPCI), myocardial no-reflow is a common phenomenon occurring in 5 to 50% of patients. The no-reflow phenomenon is a predictor of infarct size and an independent
Magro, Michael +3 more
core +14 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Molecular and Cellular Cardiology, 2012
The no-reflow phenomenon has been studied extensively in the basic science laboratory and has entered the clinical arena. No-reflow, which develops largely within the first 2h of reperfusion, is primarily the result of ischemic endothelial cell injury that obstructs the capillary lumen.
exaly +3 more sources
The no-reflow phenomenon has been studied extensively in the basic science laboratory and has entered the clinical arena. No-reflow, which develops largely within the first 2h of reperfusion, is primarily the result of ischemic endothelial cell injury that obstructs the capillary lumen.
exaly +3 more sources
Management of the no-reflow phenomenon
Pharmacology & Therapeutics, 2011The lack of reperfusion of myocardium after prolonged ischaemia that may occur despite opening of the infarct-related artery is termed "no reflow". No reflow or slow flow occurs in 3-4% of all percutaneous coronary interventions, and is most common after emergency revascularization for acute myocardial infarction.
Andrew J Taylor +2 more
exaly +3 more sources
Myocardial No-Reflow Treatment
Current Vascular Pharmacology, 2013 No-reflow phenomenon is a consequence of percutaneous coronary intervention (PCI) which arises most of the time in the setting of myocardial infarction, but can be also the consequence of PCI in stable angina patients (rotatablator ablation technique or angioplasty in saphenous vein grafts).
Olivier, Muller +2 more
core +4 more sources
Prevention and treatment of no-reflow
Acute Cardiac Care, 2010 No-reflow phenomenon occurs frequently during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction and it has a strong negative impact on outcome. Prevention of no-reflow has to be defined as any attempt to prevent its occurrence prior to or during the recanalization procedure.
Niccoli G, Marino M, Spaziani C, Crea F
openaire +5 more sources
International Journal of StrokeBackgroundThe no-reflow phenomenon refers to the absence of microvascular reperfusion despite macrovascular reperfusion.AimThe aim of this analysis was to summarize the available clinical evidence on no-reflow in patients with acute ischemic stroke ...
Felix C Ng +2 more
exaly +2 more sources
Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization [PDF]
European Heart Journal, 2006 AIMS: No-reflow after a primary percutaneous coronary intervention (PCI) is associated with a high incidence of left ventricular (LV) failure and a poor prognosis.
Carlo Trani +2 more
exaly +3 more sources
On reflow soldering process and reflow profile
2012 13th International Conference on Electronic Packaging Technology & High Density Packaging, 2012In order to obtain good welding quality, some influencing factors of reflow soldering process were studied in this research. A series of welding experiments were conducted in a small reflow soldering oven. Oxidation and surface treatment of soldering materials are important factors in the welding process.
Xulong Gui +3 more
openaire +1 more source
No-reflow phenomenon in the heart and brain
American Journal of Physiology - Heart and Circulatory Physiology, 2018 The no-reflow phenomenon refers to the observation that when an organ is made ischemic by occlusion of a large artery supplying it, restoration of patency in that artery does not restore perfusion to the microvasculature supplying the parenchyma of that
Michael Harrington, Kevin S King
exaly +2 more sources